Credit Suisse Ag Boston Scientific Corp Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Boston Scientific Corp stock. As of the latest transaction made, Credit Suisse Ag holds 2,058,101 shares of BSX stock, worth $215 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

2,058,101

Previous 2,120,966 2.96%

Holding current value

$215 Million

Previous $123 Million 14.96%

% of portfolio

0.14%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$57.6 - $68.62 $3.62 Million - $4.31 Million	-62,865 Reduced 2.96%	2,058,101 $141 Million
Q4 2023 Feb 08, 2024	BUY	$48.64 - $57.81 $6.28 Million - $7.46 Million	129,116 Added 6.48%	2,120,966 $123 Million
Q3 2023 Nov 13, 2023	BUY	$50.19 - $54.68 $111,070 - $121,006	2,213 Added 0.11%	1,991,850 $105 Million
Q2 2023 Aug 11, 2023	SELL	$49.72 - $54.64 $3.47 Million - $3.82 Million	-69,854 Reduced 3.39%	1,989,637 $108 Million
Q1 2023 May 10, 2023	SELL	$45.09 - $50.03 $832,226 - $923,403	-18,457 Reduced 0.89%	2,059,491 $103 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $468,429 - $559,132	-11,841 Reduced 0.57%	2,077,948 $96.2 Million
Q3 2022 Nov 10, 2022	SELL	$36.71 - $109.66 $1.99 Million - $5.96 Million	-54,317 Reduced 2.53%	2,089,789 $80.9 Million
Q2 2022 Aug 12, 2022	SELL	$35.24 - $47.1 $643,130 - $859,575	-18,250 Reduced 0.84%	2,144,106 $79.9 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $2.48 Million - $2.74 Million	60,757 Added 2.89%	2,162,356 $95.8 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $6.07 Million - $7.15 Million	159,323 Added 8.2%	2,101,599 $89.3 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $3.63 Million - $4.04 Million	88,002 Added 4.75%	1,942,276 $84.3 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $17.7 Million - $20.3 Million	-459,523 Reduced 19.86%	1,854,274 $80.2 Million
Q1 2021 May 14, 2021	SELL	$35.27 - $39.67 $5.6 Million - $6.3 Million	-158,817 Reduced 6.42%	2,313,797 $89.4 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $11.1 Million - $14.1 Million	334,879 Added 15.67%	2,472,614 $88.9 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $6.59 Million - $8.08 Million	-191,269 Reduced 8.21%	2,137,735 $81.7 Million
Q2 2020 Aug 12, 2020	BUY	$30.19 - $39.11 $580,161 - $751,576	19,217 Added 0.83%	2,329,004 $81.8 Million
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $2.42 Million - $4.29 Million	-93,760 Reduced 3.9%	2,309,787 $75.4 Million
Q4 2019 Feb 12, 2020	BUY	$37.87 - $45.37 $15.3 Million - $18.4 Million	405,175 Added 20.28%	2,403,547 $109 Million
Q3 2019 Nov 12, 2019	BUY	$40.31 - $43.45 $1.38 Million - $1.49 Million	34,346 Added 1.75%	1,998,372 $81.3 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $13.5 Million - $16.6 Million	385,820 Added 24.45%	1,964,026 $84.4 Million
Q1 2019 May 14, 2019	SELL	$32.91 - $40.75 $5.93 Million - $7.34 Million	-180,176 Reduced 10.25%	1,578,206 $60.6 Million
Q4 2018 Feb 13, 2019	SELL	$31.73 - $39.04 $1.91 Million - $2.35 Million	-60,298 Reduced 3.32%	1,758,382 $62.1 Million
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $2.39 Million - $2.81 Million	72,865 Added 4.17%	1,818,680 $70 Million
Q2 2018 Aug 14, 2018	SELL	$26.84 - $34.32 $1.5 Million - $1.91 Million	-55,742 Reduced 3.09%	1,745,815 $57.1 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $11 Million - $12.4 Million	-435,527 Reduced 19.47%	1,801,557 $49.2 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $5.59 Million - $6.72 Million	225,507 Added 11.21%	2,237,084 $55.5 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $1.17 Million - $1.3 Million	44,538 Added 2.26%	2,011,577 $58.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,967,039	1,967,039 $58.5 Million

Others Institutions Holding BSX

# of Institutions

1,833

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $150B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account